نتایج جستجو برای: subcutaneous allergen immunotherapy

تعداد نتایج: 78888  

Journal: :International archives of allergy and immunology 2017
Ulbosin Saltabayeva Victoria Garib Marina Morenko Rafail Rosenson Zhanat Ispayeva Madina Gatauova Loreta Zulus Alexander Karaulov Felix Gastager Rudolf Valenta

BACKGROUND Allergen molecule-based diagnosis has been suggested to facilitate the identification of disease-causing allergen sources and the prescription of allergen-specific immunotherapy (AIT). The aim of the current study was to compare allergen molecule-based IgE serology with allergen extract-based skin testing for the identification of the disease-causing allergen sources. The study was c...

Journal: :Allergy 2017
V Cardona O Luengo M Labrador-Horrillo

Allergic rhinitis and asthma constitute two clinical expressions of a single-condition, respiratory allergy. Allergen immunotherapy (AIT) is a form of treatment specifically aimed at modifying the response to sensitizing allergens. The inherent potential benefit of AIT is the simultaneous treatment of all clinical expressions of respiratory allergy. Current data support the effectiveness of sub...

2010
Susan Mikkelsen Bo Martin Bibby Mette Konow Bøgebjerg Dolberg Ronald Dahl Hans Jürgen Hoffmann

BACKGROUND Subcutaneous Immunotherapy (SCIT) modifies the allergic response and relieves allergic symptoms. SCIT is the only and a very effective treatment for insect venom allergy. We hypothesized that basophil sensitivity, measured through the basophil activation test, would decrease during SCIT up dosing. Expression of CD203c was compared to CD63 as marker for basophil activation, using a Bl...

Journal: :Cleveland Clinic Journal of Medicine 2021

Peanut and tree-nut allergies have increased dramatically in prevalence, especially children. Historically, children with food been treated through strict avoidance of the allergen. Recently, an oral preparation peanut allergen (Palforzia) was approved for immunotherapy (ie, desensitization) 4 to 17 years old. This article reviews its role allergies.

2012
Juliana De Souza Rebouças Irene Esparza Marta Ferrer María Luisa Sanz Juan Manuel Irache Carlos Gamazo

In the last decades, significant progress in research and clinics has been made to offer possible innovative therapeutics for the management of allergic diseases. However, current allergen immunotherapy shows limitations concerning the long-term efficacy and safety due to local side effects and risk of anaphylaxis. Thus, effective and safe vaccines with reduced dose of allergen have been develo...

2017
Ji Ho Lee Su Chin Kim Hyunna Choi Chang Gyu Jung Ga Young Ban Yoo Seob Shin Dong Ho Nahm Hae Sim Park Young Min Ye

Allergen-specific immunotherapy is the only causal treatment for allergic diseases. However, the efficacy of immunotherapy may vary around the world due to differences in climate, the nature of aero-allergens and their distribution. The aim of this study was to describe the effects of subcutaneous immunotherapy (SCIT) in Korean adults with allergic asthma (AA). As a retrospective cohort study, ...

Journal: :The Journal of allergy and clinical immunology 2009
Gabriele Di Lorenzo Pasquale Mansueto Maria Luisa Pacor Manfredi Rizzo Francesco Castello Nicola Martinelli Vito Ditta Claudia Lo Bianco Maria Stefania Leto-Barone Alberto D'Alcamo Gaetana Di Fede Giovam Battista Rini Anne Marie Ditto

BACKGROUND To date, no predictive tests for the clinical response to allergen-specific immunotherapy (ASI) are available. Therefore an in vivo or in vitro test would be of great value. OBJECTIVE We sought to evaluate pretreatment parameters used in diagnosing allergic rhinitis and determining serum specific IgE (s-IgE) levels, serum total IgE (t-IgE) levels, and blood eosinophil counts and to...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید